Publications

Sort by: Date | Author | Title

Rasmussen, S. B., Jensen, S. B., Nielsen, C., Quartin, E., Kato, H., Chen, ZJ., Silverman, RH., Akira, S. & Paludan, S. R. (2009). Herpes simplex virus infection is sensed by both Toll-like receptors and retinoic acid-inducible gene- like receptors, which synergize to induce type I interferon production. Journal of General Virology, 90, 74-8.
Robben, J. H., Fenton, R. A., Vargas, S. L., Schweer, H., Peti-Peterdi, J., Deen, P. M. T. & Milligan, G. (2009). Localization of the succinate receptor in the distal nephron and its signaling in polarized MDCK cells. Kidney International, 76(12), 1258-67. https://doi.org/10.1038/ki.2009.360
Rung, J., Cauchi, S., Albrechtsen, A., Shen, L., Rocheleau, G., Cavalcanti-Proença, C., Bacot, F., Balkau, B., Belisle, A., Borch-Johnsen, K., Charpentier, G., Dina, C., Durand, E., Elliott, P., Hadjadj, S., Järvelin, M.-R., Laitinen, J., Lauritzen, T., Marre, M. ... Sladek, R. (2009). Genetic variant near IRS1 is associated with type 2 diabetes, insulin resistance and hyperinsulinemia. Nature Genetics, 41(10), 1110-5. https://doi.org/10.1038/ng.443
Russell-Jones, D., Vaag, A., Schmitz, O., Sethi, B. K., Lalic, N., Antic, S., Zdravkovic, M., Ravn, G. M., Simó, R. & Liraglutide Effect and Action in Diabetes 5 (LEAD-5) met+SU Study Group (2009). Liraglutide vs insulin glargine and placebo in combination with metformin and sulfonylurea therapy in type 2 diabetes mellitus (LEAD-5 met+SU): a randomised controlled trial. Diabetologia, 52(10), 2046-55. https://doi.org/10.1007/s00125-009-1472-y
Scheen, A. J., Tan, M. H., Betteridge, D. J., Birkeland, K., Schmitz, O., Charbonnel, B. & PROactive investigators (2009). Long-term glycaemic effects of pioglitazone compared with placebo as add-on treatment to metformin or sulphonylurea monotherapy in PROactive (PROactive 18). Diabetic Medicine, 26(12), 1242-9. https://doi.org/10.1111/j.1464-5491.2009.02857.x